Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.

Fabbro M, Schuechner S, Au WW, Henderson BR.

Exp Cell Res. 2004 Aug 15;298(2):661-73.

PMID:
15265711
2.

Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking.

Henderson BR.

Bioessays. 2005 Sep;27(9):884-93. Review.

PMID:
16108063
3.

Is there more to BARD1 than BRCA1?

Irminger-Finger I, Jefford CE.

Nat Rev Cancer. 2006 May;6(5):382-91. Review.

PMID:
16633366
4.

Substrates of the BRCA1-dependent ubiquitin ligase.

Starita LM, Parvin JD.

Cancer Biol Ther. 2006 Feb;5(2):137-41. Review.

PMID:
16479151
5.

BRCA1-mediated ubiquitylation.

Boulton SJ.

Cell Cycle. 2006 Jul;5(14):1481-6. Review.

PMID:
16861894
6.

The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.

Baer R, Ludwig T.

Curr Opin Genet Dev. 2002 Feb;12(1):86-91. Review.

PMID:
11790560
7.

BRCA1-dependent and independent functions of BARD1.

Irminger-Finger I, Leung WC.

Int J Biochem Cell Biol. 2002 Jun;34(6):582-7. Review.

PMID:
11943588
8.

New concepts on BARD1: Regulator of BRCA pathways and beyond.

Irminger-Finger I, Ratajska M, Pilyugin M.

Int J Biochem Cell Biol. 2016 Mar;72:1-17. doi: 10.1016/j.biocel.2015.12.008. Review.

9.

The BRCA1 Breast Cancer Suppressor: Regulation of Transport, Dynamics, and Function at Multiple Subcellular Locations.

Henderson BR.

Scientifica (Cairo). 2012;2012:796808. doi: 10.6064/2012/796808. Review.

10.

Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.

Fukuda T, Tsuruga T, Kuroda T, Nishikawa H, Ohta T.

Curr Cancer Drug Targets. 2016;16(2):101-9. Review.

PMID:
26517537
11.

The BRCA1 ubiquitin ligase and homologous recombination repair.

Ohta T, Sato K, Wu W.

FEBS Lett. 2011 Sep 16;585(18):2836-44. doi: 10.1016/j.febslet.2011.05.005. Review.

12.

The BRCA1 E3 ubiquitin ligase controls centrosome dynamics.

Parvin JD, Sankaran S.

Cell Cycle. 2006 Sep;5(17):1946-50. Review.

PMID:
16969086
13.

BARD1, a possible biomarker for breast and ovarian cancer.

Irminger-Finger I.

Gynecol Oncol. 2010 May;117(2):211-5. doi: 10.1016/j.ygyno.2009.10.079. Review.

PMID:
19959210
14.

Factors forming the BRCA1-A complex orchestrate BRCA1 recruitment to the sites of DNA damage.

Her J, Soo Lee N, Kim Y, Kim H.

Acta Biochim Biophys Sin (Shanghai). 2016 Jul;48(7):658-64. doi: 10.1093/abbs/gmw047. Review.

PMID:
27325824
15.

Alternative splicing in cancer: implications for biology and therapy.

Chen J, Weiss WA.

Oncogene. 2015 Jan 2;34(1):1-14. doi: 10.1038/onc.2013.570. Review.

PMID:
24441040
16.

BRCA1 and p53 tumor suppressor molecules in Alzheimer's disease.

Nakanishi A, Minami A, Kitagishi Y, Ogura Y, Matsuda S.

Int J Mol Sci. 2015 Jan 28;16(2):2879-92. doi: 10.3390/ijms16022879. Review.

17.

Changing venues for tumour suppression: balancing destruction and localization by monoubiquitylation.

Salmena L, Pandolfi PP.

Nat Rev Cancer. 2007 Jun;7(6):409-13. Review.

PMID:
17508027
18.

Recent advances in the research for the homolog of breast cancer associated gene AtROW1 in higher plants.

Jiao Y, Zhang Y, Zhu YX.

Sci China Life Sci. 2016 Aug;59(8):825-31. doi: 10.1007/s11427-016-5086-6. Review.

PMID:
27502904
19.

[Progress in the effects of BRAP gene on cardiovascular diseases].

Lv D, Zhu YM.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Sep;43(5):602-6. Review. Chinese.

PMID:
25372649

Supplemental Content

Support Center